Drug intelligence / Profile preview

索罗玛宝颗粒

Development stage: Unknown
Lead developer: Xizang Ganlu Tibetan Medicine
Administration: Oral

Overview

索罗玛宝颗粒是一种口服藏药颗粒制剂，由大花红景天制成。西藏甘露藏药将其用于高原适应不全症，说明书所载功能为益气安神、抗缺氧和抗疲劳；其批准文号为国药准字Z20020028，规格为每袋3克。该产品的明确分子靶点和经验证的现代药理机制未在公司公开说明书中披露。 ([glzy.cn](https://www.glzy.cn/index/product/detail/id/96.html))

Other names: Suoluomabao Granules索罗玛宝

Beyond the preview

Go deeper on 索罗玛宝颗粒.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 索罗玛宝颗粒.

Explore the full profile